What 'First New Filter in Decades' Actually Means
Putting the bemotrizinol milestone in historical context.
Bemotrizinol is the first new active in the U.S. OTC sunscreen monograph since the late 1990s.
Regulatory analysts note that the US OTC sunscreen monograph effectively froze for decades, so bemotrizinol's June 2026 order is the first time in a generation a new filter cleared the FDA.
Questions we get a lot
What is bemotrizinol (Parsol Shield)?
Bemotrizinol (trade name Parsol Shield; also known as Tinosorb S) is a broad-spectrum UVA+UVB filter that is highly photostable. On June 9, 2026 the FDA approved it — the first new sunscreen active added to the US monograph since the 1990s — for adults and children 6 months and older at up to 6%.
Why did it take decades to add a new US sunscreen filter?
The US regulates sunscreens as over-the-counter drugs, so adding a filter requires drug-level safety data and FDA action rather than a faster cosmetic review. The OTC monograph stayed effectively frozen for years until reform created a workable pathway, which is how bemotrizinol finally cleared in 2026.
Why are some UV filters more photostable?
A photostable filter keeps absorbing UV without breaking down in sunlight. Older filters like avobenzone can lose protection within an hour unless paired with stabilizers such as octocrylene. Newer filters like bemotrizinol are engineered to stay chemically stable, so protection lasts longer — though reapplication is still advised.
r/SkincareAddiction: 'Is bemotrizinol finally coming to US sunscreens?'